Experts discuss the potential of linvoseltamab in treating high-risk smoldering multiple myeloma, highlighting promising early trial results and response rates.
Paula Rodriguez-Otero, MD, PhD
Advertisement
Articles by Paula Rodriguez-Otero, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
ACIP Meeting: Combined MMRV Vaccine, Hepatitis B Vaccine Restricted for Some Age Groups
2
FDA Approves 1.5% Ruxolitinib Cream for Pediatric Atopic Dermatitis
3
IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
4
Infection Risk Management in Patients With Multiple Myeloma on T-Cell Engaging Therapies
5
